Post-Viral Trials

Post-Viral Trials

@postviraltrials.bsky.social

News and information about interventional trials for Long Covid, ME/CFS, POTS, and other post-viral illnesses. Message or tag me if you’re in a trial or otherwise have information to share.

1,971 Followers 65 Following 138 Posts Joined Oct 2024
18 hours ago

I’ve tried 14 of these, and then some. IVIg, midodrine, and Mestinon are the ones on the list I’d most highly recommend; tVNS not on the list; and exercise-based physical therapy once you’re doing some of these things and want to test if it’s working well.

1 0 0 0
3 days ago

📢 Researchers! The Congressionally Directed Medical Research Program (CDMRP) is taking applications for the 2026 Peer-Reviewed Medical Research Program (PRMRP) Awards. Areas include #MECFS, Ehlers-Danlos Syndrome, & Mitochondrial Disease, among others.
Learn more: https://ow.ly/HPv150YrACP.

8 4 0 0
3 days ago
Preview
A phase 2a double-blind, placebo-controlled randomized trial of the SARS-CoV-2-specific monoclonal antibody AER002 in people with Long COVID Long COVID is a disabling chronic illness with no proven treatments. Persistence of SARS-CoV-2 has been proposed as a biological driver of the disease. We conducted a placebo-controlled, double-blind,...

UCSF study of 36 people with Long COVID finds a single infusion of the SARS-CoV-2 antibody AER002 was safe but did not improve symptoms or quality of life versus placebo though people with lower virus antibody levels showed hints of benefit.

www.medrxiv.org/content/10.6...

10 5 1 1
3 days ago

Last week a long article about #BC007 was published here in Germany.

In short: A new company named APTA Therapeutics, which largely consists of former BerlinCures employees, will continue to explore the drug's potential for #MECFS and #LongCOVID.

www.riffreporter.de/de/wissen/lo...

15 4 0 0
1 week ago
Promotional graphic for an ME/CFS research opportunity featuring lab glassware and a microscope in a blue-toned laboratory; logos for Baker Heart & Diabetes Institute and The University of Melbourne appear at the top, and Emerge Australia logo at the bottom. Text reads: “ME/CFS research opportunity” and “How is blood flow changed in those with ME/CFS and OI during exercise and how does that impact PEM?”

Recruitment call 📣

The Baker Institute / Uni of Melbourne are recruiting adults (18+) with ME/CFS or orthostatic intolerance for a study in Melbourne (2 clinic visits, parking + time reimbursed).

More info: zurl.co/tYcRE

#MECFS #EmergeAustralia #BakerInstitute

4 4 0 0
6 days ago
Post image

1) 🇰🇷 A study from South-Korea shows that Metformin (the diabetes drug) and Ursodeoxycholic Acid (a bile acid) are not effective in Long Covid.

Most patients improved at lot, even those in the placebo group.

12 8 2 0
6 days ago
Preview
Divisive F.D.A. Vaccine Regulator Resigns Dr. Vinay Prasad drew criticism for decisions that overrode agency scientists and rejected potential drugs.

Breaking News: Dr. Vinay Prasad, a polarizing figure at the FDA who oversaw vaccines, is leaving the agency. As the FDA’s chief science and medical officer, he made several controversial decisions, including overruling career scientists on some vaccine approvals.

191 55 21 27
1 week ago
Preview
Immunoglobulin G complexes from post-infectious ME/CFS, including post-COVID ME/CFS disrupt cellular energetics and alter inflammatory marker secretion Autoimmunity is a key clinical feature in both post-infectious Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and Post-Acute Sequelae of …

www.sciencedirect.com/science/arti...

10 5 0 0
2 weeks ago
Post image

1) Prof Jeroen Den Dunnen won a prestigious Vici grant (€ 1.5M) for his research on antibodies in post-acute infection syndromes such as ME/CFS.

Vici is one of the largest personal scientific grants in the Netherlands. It's the first time it has been awarded to PAIS research.

33 9 1 1
2 weeks ago
Post image

1) 🇩🇪 The steering committee for the National Decade against Post-Infectious Diseases agreed on three measures to be implemented at the start of the decade, includes a genome sequencing project.

(An automatic translation of the German statement is pasted in the image below)

20 10 1 0
1 week ago

Great news!

1 0 1 0
2 weeks ago
Post image

1) This new paper in the Lancet suggests that the risk of Long Covid has substantially decreased compared to the pandemic period. The excess prevalence of severe symptoms self-attributed to SARS-CoV-2 was only 0.3% after 180 days.

A brief breakdown...

12 4 1 0
2 weeks ago
RECOVER-TLC seeks input on planned study of possible Long COVID treatment

Announcement
February 23, 2026 1 min read
Members of the public will have two weeks to provide feedback on a clinical trial testing the safety and effectiveness of a medical procedure that could help people experiencing a range of Long COVID symptoms.

RECOVER-Treating Long COVID (RECOVER-TLC) invites patients, caregivers, advocates, healthcare providers, and researchers to provide feedback on its upcoming stellate ganglion nerve block (SGB) clinical trial.

RECOVER-TLC wants to collect feedback on this planned clinical trial in the form of public comments on the draft SGB Protocol Synopsis. This draft protocol synopsis (brief summary) contains information about the questions the study will investigate, how researchers will look for answers, and who can join the study. The draft SGB Protocol Synopsis and comment submission form will be made available on the RECOVER-TLC Collaborator Portal on February 23 and will remain accessible for 2 weeks, closing on March 8 at 11:59 pm ET.

RECOVER-TLC seeks input on planned study of possible Long COVID treatment [stellate ganglion nerve block (SGB)]

recovercovid.org/news/recover...

#LongCovid #SGB

10 9 2 1
3 weeks ago
Preview
Short and long term effects of a two-week transcutaneous vagus nerve stimulation in hyperadrenergic postural orthostatic tachycardia syndrome: a proof-of-concept trial Hyperadrenergic POTS (Hyper-POTS) is characterized by excessive central sympathetic activity and impaired cardiovagal modulation. A single transcutane…

“Fourteen-day tVNS enhanced cardiovagal modulation, reduced sympathetic activity, and improved orthostatic symptoms in Hyper-POTS patients. Additionally, some benefits persisted beyond the stimulation period. Thus, tVNS could potentially be used as an additional therapeutic tool in Hyper-POTS.”

5 1 0 0
3 weeks ago

5) For people in the US:

Yarred Younger registered a trial of LDN here:
clinicaltrials.gov/s...

David Systrom is also testing LDN in the LIFT trial, more info here:
www.omf.ngo/the-life...

4 1 0 0
3 weeks ago
Preview
Griffith University Griffith Uni ranks in the top 2 percent of universities globally with 50,000 students spanning six campuses in South East Queensland, Australia.

4) At the end of 2026, they hope to recruit in Victoria. To register your interest or request further information, people can email: ncned@griffith.edu.au

Info taken from:
www.facebook.com/100...

4 3 1 0
3 weeks ago
Post image

1) 🇦🇺 The NCNED team of Prof. Sonya Marshall-Gradisnik is launching a double blind trial of low dose naltrexone (LDN) in patients with ME/CFS.

They are currently looking for patients diagnosed by the CCC/ICC located in South-East Queensland and Northern New South Wales.

15 7 2 1
3 weeks ago
Preview
FDA reverses course, agrees to review Moderna’s flu vaccine The FDA reversed course and told Moderna it would review its application for a new flu vaccine, the company announced Wednesday.

“The Food and Drug Administration reversed course and told Moderna it would review its application for a new flu vaccine… The FDA will now review the product in adults 50 to 64 through a regular pathway, and adults over 65 via accelerated approval with a requirement to run a post-marketing study.”

100 52 2 14
3 weeks ago

I use inTENSity from this brand

1 0 1 0
3 weeks ago

The downside of other high-income countries negotiating down drug prices so far and relying on the US’s crazy prices to fund pharma R&D is that when we elect an anti-vax moron, nobody gets vaccines anymore. It’s not just defense that Europe has outsourced to America.

4 0 0 0
1 month ago

Brief description: double-blind, placebo-controlled investigation of pyridostigmine (Mestinon) and low dose naltrexone (LDN)

Time required: 3 months, 3 onsite visits, 4 virtual visits

Study tasks: sub-maximal exercise test(s), biweekly questionnaires and brain games, blood draws

9 2 0 0
1 month ago
On the right, eligibility criteria are listed: ages 18–65, meet Canadian Consensus Criteria for ME/CFS with orthostatic intolerance, symptom onset before December 2023, ability to meet study requirements, and possession of a functioning smartphone. Below, text invites participation through OMF’s StudyME Registry at www.omf.ngo/studyme

The Mestinon/LDN Life Improvement Trial (LIFT) is seeking eligible research participants now within 300 miles of Brigham and Women’s Hospital at Harvard Medical School.

Learn more about the LIFT: https://clinicaltrials.gov/study/NCT06366724

25 21 1 0
1 month ago

3) Low-Dose Sirolimus (Rapamycin) for Long COVID
clinicaltrials.gov/study/NCT069...

4) NE3107 for Long COVID
clinicaltrials.gov/study/NCT068...

5) Tafenoquine for Babesiosis with Severe Fatigue
clinicaltrials.gov/study/NCT066...

13 5 0 1
1 month ago

1) Lumbrokinase for LC, ME/CFS, Post-Treatment Lyme Disease
clinicaltrials.gov/study/NCT065...

2) Antivirals for Long COVID
Trial will test if two repurposed HIV antivirals can reduce symptom burden in adult participants with Long Covid compared to placebo.
clinicaltrials.gov/study/NCT065...

11 5 1 0
1 month ago
cheery pink background with white and green pills in the foreground

One of the best sites running a wide variety of clinical trials for #LongCovid and other IACCs is @coresinai.bsky.social, via @putrinolab.bsky.social !

At least 5 trials are currently recruiting - see links below for eligibility!

26 15 2 0
1 month ago

👏

1 0 0 0
1 month ago
Post image

1) The Dutch NMCB research consortium held its General Assembly. Researchers of multiple ME/CFS studies reported their current status and findings.

Here are a couple of things that caught our attention...

17 7 1 2
1 month ago

…got nowhere to go. I can see how if you have a mortgage you wouldn’t want home values to fall a ton, but rising values don’t really help anybody (most people like where they live and want to retire there, not in West Virginia or Mexico or somewhere much cheaper).

0 0 0 0
1 month ago

Are you planning to sell your home and move to a much lower cost-of-living place in retirement? If not, I’m not sure how high home values help you. The cost of living goes up since everybody who provides you services demands more money for rent, and you can’t sell your home since you’ve…

0 0 1 0
1 month ago

A team at Amsterdam UMC will test fluvoxamine (an SSRI) as a treatment for #PostCOVID in a phase III RCT.

Fluvoxamine “may reduce PC symptoms because of its regulatory effect on the (neuro) immune system, the HPA axis and the tryptophan system.“

clinicaltrials.gov/study/NCT073...

8 2 1 0